HaoFeng Medical and Medico Medical Technology Awarded as Shanghai's First Batch of Technology-Based SMEs in 2024

Since its establishment, Haofeng Medical has always followed the pace of China's innovation-driven development strategy, continuously increasing investment in technological innovation.The company has built four major industrial platforms: the Component Platform, dedicated to contract research and contract manufacturing of interventional consumables; the Equipment Platform, focusing on the production line manufacturing and testing equipment for medical devices; the Material Platform, concentrating on raw material R&D, catheter and post-catheter processing, providing customized services; the Energy Platform, mainly developing active medical device equipment hosts and consumables.

Innovation is the core engine driving the high-quality development of the medical industry. Therefore,Haofeng Medical has assembled a team of engineers and management personnel with an average of ten years of industry experience. Through relentless efforts, Haofeng Medical Group and its subsidiaries have successfully obtained recognition for over 130 national patents.

Haofeng Medical's core innovation capability focuses on the innovation of processes and production flows. We started in the field of high-end manufacturing equipment, rather than tracing upstream from downstream products to components. This allows us to grasp the source of core technologies, possess the ability to optimize production processes and flows, and avoid competition with our downstream customers. We can achieve high-precision, high-efficiency, and high-quality processing and production, providing customers with products of excellent performance.

Meduco Medical, a subsidiary of Shanghai Hao Feng Group, focuses on contract research and manufacturing services for medical devices, particularly excelling in access-related medical devices such as guidewires, catheters, and balloon catheters. The company demonstrates strong technological innovation and market competitiveness. Meduco Medical offers one-stop, full product lifecycle R&D and manufacturing services, helping clients accelerate product time-to-market and reduce R&D risks.

According to the "Evaluation Method for Science and Technology-Based Small and Medium Enterprises," Haofeng Medical and Meduk Medical have successfully obtained national recognition as science and technology-based small and medium enterprises after a rigorous review. This honor not only affirms their technological innovation capabilities and market potential but also opens up broader opportunities for both companies in scientific research projects, the introduction of high-level talent, and brand internationalization.

Looking ahead, Haofeng Medical and Medcore will continue to adhere to the concept of innovation-driven development, deepen technological capabilities, expand application areas, strengthen international cooperation, and jointly promote the intelligent and precise transformation of the healthcare industry.